Axio is a premier provider of biostatistics and data management services to pharmaceutical, biotechnology, and medical device companies.
We are focused exclusively on delivering timely, high-quality data and thoughtful analysis to help our clients develop, execute, evaluate, and document clinical studies confidently and efficiently.
Our company was founded in 1979 by an internationally recognized group of biostatisticians and epidemiologists from the University of Washington, many of whom remain closely involved with the company. Their vision was to create a flexible, responsive organization to facilitate their clinical trials and research.
Axio today reflects that pedigree—a world-class team of management and PhD/MS statisticians and programmers and a recognized leader in biostatistics-related clinical trial support services.
Our industry-leading Data Monitoring Committee services, deep biostatistics expertise, operational flexibility, and experience across diverse therapeutic areas are the basis of the value we bring to large pharmaceutical and small biotechnology companies alike.
The depth of expertise and experience of our professional staff is reflected in the results we have achieved for our clients, encompassing:
- 300+ studies, including >200 Data Monitoring Committee projects
- Clinical research experience spanning all major therapeutic areas
- Professional biostatistics staff >30 (>55% of total staff)
- 11 years average clinical trials experience among senior management
Today and ongoing, Axio’s chief commitment is to our clients’ success, and to continually improving our systems and services to help our clients optimize productivity and mitigate risk in the clinical trials process.